The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,701–17,800 of 31,469
Waldman, H. S., Smith, J. W., Lamberth, J., Fountain, B. J., Bloomer, R. J., Butawan, M. B., & McAllister, M. J. (2020) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003749 · Cited by 16
Hussein, A., Fouda, K. A., Mehaya, F. M., Mohamed, D. A., Mohammad, A. A., Abdelgayed, S. S., & Mohamed, R. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04593 · Cited by 16
Ho, C., Chang, P., Chen, H.-W., Lee, P.-F., Chang, Y.-C., Tseng, C.-Y., & Lin, P. (2020) · Antioxidants · doi:10.3390/antiox9090823 · Cited by 16
Chahal, N., Quinn, M. M., Greenwood, E. A., Kao, C., Cedars, M. I., & Huddleston, H. G. (2020) · F&S Reports · doi:10.1016/j.xfre.2020.09.008 · Cited by 15
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy
Kralisch, S., Hoffmann, A., Estrada-Kunz, J., Stümvoll, M., Faßhauer, M., Tönjes, A., & Miehle, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197214 · Cited by 15
Motamed, S., Nikooyeh, B., Kashanian, M., Chamani, M., Hollis, B. W., & Neyestani, T. R. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03311-1 · Cited by 15
Shivashankara, A. R., D’Cunha, P., & Rebeiro, C. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00672-4 · Cited by 17
Emara, N. A., Mahmoud, M. F., Fayoumi, H. M. E., et al. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02012-y · Cited by 15
Bang, J. B., Oh, C., Kim, Y. S., Kim, S. H., Yu, H. C., Kim, C., Ju, M. K., So, B. J., Lee, S. H., Han, S. Y., et al. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.743 · Cited by 15
Sitasuwan, T., & Lertwattanarak, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041269 · Cited by 15
Arya, R., Farook, V. S., Fowler, S. P., Puppala, S., Chittoor, G., Resendez, R. G., Mummidi, S., Vanamala, J., Almasy, L. A., Curran, J. E., et al. (2018) · Genetic Epidemiology · doi:10.1002/gepi.22114 · Cited by 16
Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile
Noronha, R. M., Villares, S. M. F., Torres, N., et al. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62039 · Cited by 15
Quitete, F. T., Santos, G. M. A., Ribeiro, L. D. O., da Costa, C. A., Freitas, S. P., da Matta, V. M., & Daleprane, J. B. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109369 · Cited by 15
Roy, D., Purohit, P., Modi, A., Khokhar, M., Shukla, R. K. G., Chaudhary, R., Sankanagoudar, S., & Sharma, P. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210104101739 · Cited by 18
Jia, W., Jia, Q., Zhang, Y., et al. (2021) · Neurological Research · doi:10.1080/01616412.2020.1866371 · Cited by 15
Abbate, M., Mascaró, C. M., Montemayor, S., Casares, M., Gómez, C., Ugarriza, L., Tejada, S., Abete, I., Zulet, M. Á., Sureda, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081717 · Cited by 15
Chlabicz, M., Jamiołkowski, J., Łaguna, W., Sowa, P., Paniczko, M., Łapińska, M., Szpakowicz, M., Drobek, N., Raczkowski, A., & Kamiński, K. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081584 · Cited by 15
Buchmann, N., Eckstein, N., Spira, D., Demuth, I., Steinhagen‐Thiessen, E., & Norman, K. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3457 · Cited by 15
Selma-Gracia, R., Megušar, P., Haros, C. M., & Laparra, J. M. (2021) · Nutrients · doi:10.3390/nu13051537 · Cited by 15
Wagner, J. A., Bermúdez‐Millán, A., Buckley, T., Buxton, O. M., Feinn, R., Kong, S., Kuoch, T., Nahmod, N. G., & Scully, M. F. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106427 · Cited by 16
Ramos-García, M., Blé‐Castillo, J. L., García-Vázquez, C., Tovilla‐Zárate, C. A., Juárez‐Rojop, I. E., Olvera‐Hernández, V., Mendoza, A. D. G., Córdova-Uscanga, R., Álvarez‐González, C. A., & Díaz-Zagoya, J. C. (2021) · Foods · doi:10.3390/foods10050958 · Cited by 15
Smith, K., Taylor, G., Allerton, D. M., Brunsgaard, L. H., Davies, K. A. B., Stevenson, E., & West, D. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.696977 · Cited by 17
Kim, H., Lee, M., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0273 · Cited by 16
Perng, W., Kelsey, M. M., Sauder, K. A., & Dabelea, D. (2021) · Diabetologia · doi:10.1007/s00125-021-05515-2 · Cited by 15
Psychological Resources and Biomarkers of Health in the Context of Chronic Parenting Stress
Crosswell, A., Sagui-Henson, S. J., Prather, A., Coccia, M. A., Irwin, M. R., & Epel, E. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-10007-z · Cited by 16
Furuhashi, M., Muranaka, A., Yuda, S., Tanaka, M., Koyama, M., Kawamukai-Nishida, M., Takahashi, S., Higashiura, Y., Miyamori, D., Nishikawa, R., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.07.047 · Cited by 15
Azizian, H., Khaksari, M., Asadikaram, G., et al. (2021) · Biomedical Journal · doi:10.1016/j.bj.2020.03.002 · Cited by 15
Li, L., Spranger, L., Stobäus, N., Beer, F., Decker, A.-M., Wernicke, C., Brachs, S., Brachs, M., Spranger, J., & Mai, K. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00174-z · Cited by 14
Oh, H., Nguyen, H. D., Yoon, I. M., Ahn, B.-R., & Kim, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-00418-z · Cited by 15
Green tea aqueous extract (GTAE) prevents high‐fat diet‐induced obesity by activating fat browning
Li, J., Chen, Q., Zhai, X., Wang, D., Hou, Y., & Tang, M. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2580 · Cited by 14
Li, G., Zhong, L., Han, L., Wang, Y., Li, B., Wang, D., Zhao, Y., Li, Y., Zhang, Q., Qi, L., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01004-z · Cited by 15
Kastberg, S. E., Lund, H. S., Rolfe, E. D. L., Kaduka, L. U., Boit, M. K., Corpeleijn, E., Friis, H., Bernard, S., Paquette, M., Baass, A. W., et al. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13696 · Cited by 15
Cardiovascular Risk, Obesity, and Sociodemographic Indicators in a Brazilian Population
Moreira, N. C. D. V., Mdala, I., Hussain, A., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.725009 · Cited by 15
Kim, H. Y., Yoon, J.-J., Lee, H.-K., Tai, A.-L., Lee, Y. J., Kim, D., Kang, D.-G., & Lee, H.-S. (2021) · Nutrients · doi:10.3390/nu13114177 · Cited by 14
Farkas, G. J., Gordon, P., Trewick, N., Gorgey, A. S., Dolbow, D. R., Tiozzo, E., Berg, A. S., & Gater, D. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235591 · Cited by 16
Lee, S. J., Kim, H., Oh, B. K., Choi, H., Lee, J., Lee, S. H., Kim, B. J., Kim, B. S., Kang, J. H., Kang, J., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.12.003 · Cited by 15
Slow oscillations persist in pancreatic beta cells lacking phosphofructokinase M
Marinelli, I., Parekh, V. S., Fletcher, P. A., Thompson, B. M., Ren, J., Tang, X., Saunders, T. L., Ha, J., Sherman, A., Bertram, R., et al. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.01.027 · Cited by 15
Wu, Y., Shi, J., Su, Q., YANG, Z. K., & Qin, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.826757 · Cited by 15
van de Pas, K. G. H., Lubrecht, J., Hesselink, M. L., Winkens, B., van Dielen, F. M. H., & Vreugdenhil, A. C. E. (2022) · Nutrients · doi:10.3390/nu14091795 · Cited by 18
Huvinen, E., Lahti, J. M. T., Klemetti, M. M., Bergman, P., Räikkönen, K., Orho‐Melander, M., Laivuori, H. M., & Koivusalo, S. B. (2022) · Diabetologia · doi:10.1007/s00125-022-05712-7 · Cited by 19
Masoudi, F., Sharifi, M., & Pourfarzam, M. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.343078 · Cited by 15
Zhang, J., Pivovarova‐Ramich, O., Kabisch, S., Markova, M., Hornemann, S., Sucher, S., Rohn, S., Machann, J., & Pfeiffer, A. F. H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.808346 · Cited by 20
Høgh, J., Hove‐Skovsgaard, M., Gelpi, M., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07485-1 · Cited by 15
Carpentieri, G. B., Gonçalves, S. E. A. B., Casagrande, M. Z., Mourad, W. M., Pinto, L. G. C., & Zanella, M. T. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06119-4 · Cited by 15
Vigna, L., Tirelli, A. S., Gaggini, M., Piazza, S. D., Tomaino, L., Turolo, S., Moroncini, G., Chatzianagnostou, K., Bamonti, F., & Vassalle, C. (2022) · Endocrine · doi:10.1007/s12020-022-03087-8 · Cited by 15
Buell‐Acosta, J. D., Garcés, M. F., Baños, A. J. P., Ángel‐Müller, E., Páez, M. C., Eslava-Schmalbach, J. H., Escobar-Córdoba, F., Caminos-Cepeda, S. A., Lacunza, E., Castano, J. P., et al. (2022) · Cells · doi:10.3390/cells11142251 · Cited by 15
Smell Impairment in Stage I‐II Obesity: Correlation with Biochemical Regulators and Clinical Aspects
Micarelli, A., Mrakic‐Sposta, S., Micarelli, B., Malacrida, S., Misici, I., Carbini, V., Iennaco, I., Caputo, S., Vezzoli, A., & Alessandrini, M. (2022) · The Laryngoscope · doi:10.1002/lary.30325 · Cited by 15
Overweight and Obesity Are Positively Associated with Serum Copper Levels in Mexican Schoolchildren
Vázquez‐Moreno, M. A., Sandoval-Castillo, M., Ríos-Lugo, M. J., et al. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03383-4 · Cited by 15
Wilson, S. M. G., Peterson, E. J., Gaston, M. E., Kuo, W., & Miles, M. P. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.08.002 · Cited by 17
Quantifying the contribution of triglycerides to metabolic resilience through the mixed meal model
O’Donovan, S. D., Erdõs, B., Jacobs, D. M., Wanders, A. J., Thomas, E. L., Bell, J. D., Rundle, M., Frost, G. S., Arts, I. C. W., Afman, L. A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105206 · Cited by 15
El-attar, A. A., Ibrahim, O. M., Alhassanin, S. A., Essa, E. S., & Mostafa, T. M. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03444-6 · Cited by 15
Marciniak, M., Sato, M., Rutkowski, R., Zawada, A. E., Juchacz, A., Mahadea, D., Grzymislawski, M. B., Dobrowolska, A., Kawka, E., Korybalska, K., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1078508 · Cited by 15
Şahin, S. B., Durakoğlugil, T., Ayaz, T., Şahin, O. Z., Durakoğlugil, M. E., Sümer, F., Aktaş, E., & Alyildiz, N. (2015) · Endocrine Practice · doi:10.4158/ep14435.or · Cited by 15
The adipokine preadipocyte factor-1 is downregulated in preeclampsia and expressed in placenta
Schrey-Petersen, S., Wurst, U., Ebert, T., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.021 · Cited by 15
Plasma proteomic analysis in obese and overweight prepubertal children
Galata, Z., Moschonis, G., Makridakis, M., Dimitraki, P., Nicolaides, N. C., Μanios, Y., Bartzeliotou, Α., Chrousos, G. P., & Charmandari, E. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02536.x · Cited by 15
Hioki, M., Kanehira, N., Koike, T., Saito, A., Takahashi, H., Shimaoka, K., Sakakibara, H., Oshida, Y., & Akima, H. (2016) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12250 · Cited by 17
Kordi, M. R., Choopani, S., Hemmatinafar, M., & Choopani, Z. (2013) · Pars of Jahrom University of Medical Sciences · doi:10.29252/jmj.11.1.4 · Cited by 15
Adiponectin and bone metabolism markers in female rowers: eumenorrheic and oral contraceptive users.
Jürimäe, J., Vaiksaar, S., Mäestu, J., Purge, P., & Jürimäe, T. (2011) · PubMed · doi:10.3275/7415 · Cited by 15
Larsen, L. H., Ørstrup, L. K. H., Hansen, S. H., Grunnet, N., Quistorff, B., & Mortensen, O. H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6093-0_5 · Cited by 15
Bonora, B. M., Marescotti, M. C., Marcuzzo, G., Avogaro, A., & Fadini, G. P. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0163 · Cited by 15
New Solutions for Type 2 Diabetes Mellitus
Grossman, L. D. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220001-00001 · Cited by 15
Hileman, C. O., Dirajlal‐Fargo, S., Lam, S. K., Kumar, J., Lacher, C. P., Combs, G. F., & McComsey, G. A. (2015) · Journal of Nutrition · doi:10.3945/jn.115.214577 · Cited by 15
Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men
Oka, R., Kobayashi, J., Inazu, A., Yagi, K., Miyamoto, S., Sakurai, M., Nakamura, K., Miura, K., Nakagawa, H., & Yamagishi, M. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.020 · Cited by 15
Berings, M., Wehlou, C., Verrijken, A., Deschepper, E., Mertens, I. L., Kaufman, J., Gaal, L. F. V., Ouwens, D. M., & Ruige, J. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045145 · Cited by 17
Canis, R., Demirkök, S. S., Oşar, Z., Balcı, H., & Can, G. (2007) · Advances in Therapy · doi:10.1007/bf02848778 · Cited by 15
Boehncke, S., Salgo, R., Garbaravičienė, J., Beschmann, H. A., Ackermann, H., Boehncke, W., & Ochsendorf, F. R. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1157-5 · Cited by 15
Relationship between peak oxygen uptake and regional body composition in Japanese subjects
Oda, K., Miyatake, N., Sakano, N., Saito, T., Miyachi, M., Tabata, I., & Numata, T. (2013) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2012.11.006 · Cited by 16
Association of sleep duration and insulin resistance in Taiwanese vegetarians
Chang, J., Koo, M., Kao, V. Y.-Y., & Chiang, J. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-666 · Cited by 16
Ng, T., Ooi, E. M. M., Watts, G. F., Chan, D. C., & Barrett, P. H. R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12243 · Cited by 15
Li, C., Yang, H., Tong, G., Shen, S., Feng, W., Bi, Y., & Zhu, D. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0563-5 · Cited by 16
Han, J. H., Lee, Y. T., Kwak, K. W., Ahn, S. H., Chang, I. H., Myung, S. C., Oh, S., Lee, Y., Kim, W., Jin, Y.-W., et al. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2009.90 · Cited by 15
Zeba, A. N., Delisle, H. F., Rossier, C., & Renier, G. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512003182 · Cited by 15
Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations
Nishiyama, A., Yagi, M., Awano, H., Okizuka, Y., Maeda, T., Yoshida, S., Takeshima, Y., & Matsuo, M. (2009) · Pediatrics International · doi:10.1111/j.1442-200x.2009.02863.x · Cited by 15
Savastano, S., Barbato, A., Somma, C. D., Guida, B., Pizza, G., Barrea, L., Avallone, S., di Cola, M. S., Strazzullo, P., & Colao, A. (2012) · PubMed · doi:10.3275/8511 · Cited by 15
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2012.12.021 · Cited by 15
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women
Santini, F., Giannetti, M., Mazzeo, S., Fierabracci, P., Scartabelli, G., Marsili, A., Valeriano, R., Pucci, A. B. F., Anselmino, M., Zampa, V., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347407 · Cited by 15
Korwutthikulrangsri, M., Mahachoklertwattana, P., Chanprasertyothin, S., Pongratanakul, S., & Poomthavorn, P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12808 · Cited by 15
Park, J., Gong, J., Hong, H.-R., et al. (2013) · Physical Activity and Nutrition · doi:10.5717/jenb.2013.17.4.143 · Cited by 15
Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
Montali, A., Truglio, G., Martino, F., Ceci, F., Ferraguti, G., Ciociola, E., Maranghi, M., Gianfagna, F., Iacoviello, L., Ström, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120099 · Cited by 16
Migration is associated with lower total, but not free testosterone levels in South Asian men
Heald, A. H., Patel, J. V., Anderson, S. G., Vyas, A., Rudenski, A. S., Hughes, E. A., Panja, N., Ullah, A., Prabhakaran, D., Reddy, S., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02856.x · Cited by 15
Self-citationZyriax, B., Salazar, R., Hoeppner, W., Vettorazzi, E., Herder, C., & Windler, E. E. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075807 · Cited by 15
Bleil, M. E., Appelhans, B. M., Latham, M. D., Irving, M. A., Gregorich, S. E., Adler, N. E., & Cedars, M. I. (2015) · Nursing Research · doi:10.1097/nnr.0000000000000096 · Cited by 15
Dégi, A. A., Kis, É., Kerti, A., et al. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.05.060 · Cited by 15
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease
Bianchi, G. P., Bugianesi, E., Frystyk, J., Tarnow, L., Flyvbjerg, A., & Marchesini, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.05.011 · Cited by 15
Interaction betweenPPARGPro12Ala andADIPOQG276T concerning cholesterol levels in childhood obesity
Johansson, L. E., Danielsson, P., Norgren, S., et al. (2008) · International Journal of Pediatric Obesity · doi:10.1080/17477160802263194 · Cited by 15
Kinra, S., Johnson, M., Kulkarni, B., Sarma, K. V. R., Ben‐Shlomo, Y., & Smith, G. D. (2014) · Public Health · doi:10.1016/j.puhe.2014.06.005 · Cited by 15
Kwan, P., Yip, F. P., Hui, A. C.-F., Leung, H., Ng, P. W., Hui, K. F., Chan, I. H.-S., Chan, M. H. M., & Lam, C. W. K. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.01.010 · Cited by 15
Takeguchi, F., Nakayama, M., & Nakao, T. (2008) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2008.00581.x · Cited by 15
Cuesta‐Sancho, S., Kireev, R. A., Forman, K., Garcı́a, C., Acuña-Castroviejo, D., Vara, E., & Tresguerres, J. A. F. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.12.007 · Cited by 14
Zabaleta, J., Velasco‐Gonzalez, C., Estrada, J., Ravussin, É., Pelligrino, N. E., Mohler, M. C., Larson‐Meyer, E., Boulares, A. H., Powell-Young, Y. M., Bennett, B., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.220 · Cited by 15
Effect of Weight Loss on Serum Osteocalcin and Its Association with Serum Adipokines
Albadah, M. S., Dekhil, H., Shaik, S. A., Alsaif, M. A., Shogair, M., Nawaz, S., & Alfadda, A. A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/508532 · Cited by 15
Sasaki, J., Otonari, T., Uchida, Y., Ikeda, Y., Biro, S., & Kono, S. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13532 · Cited by 15
Winzer, B., Paratz, J. D., Reeves, M. M., & Whiteman, D. C. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-292 · Cited by 15
HEPATITIS C AND INSULIN RESISTANCE: MUTUAL INTERACTIONS. A REVIEW
Decock, S., Verslype, C., & Fevery, J. (2007) · Acta Clinica Belgica · doi:10.1179/acb.2007.019 · Cited by 14
Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents
Zhu, J., Liang, L., Zou, C., et al. (2010) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-010-0494-2 · Cited by 15
Çetinkalp, Ş., Karadeniz, M., Erdoğan, M., Zengi, A., Çetintaş, V. B., Vardarli, A. T., Eroğlu, Z., Kosova, B., Özgen, G., Saygılı, F., et al. (2008) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-008-9280-8 · Cited by 15
Grover‐Páez, F., Zavalza-Gómez, A. B., & Anaya‐Prado, R. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788628 · Cited by 15
Cheang, K. I., Essah, P. A., Sharma, S. T., Wickham, E. P., & Nestler, J. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.039 · Cited by 17
Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis
Abe, M., Kikuchi, F., Okada, K., Kaizu, K., & Matsumoto, K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.028 · Cited by 15
Katabami, T., Kato, H., Shirai, N., et al. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.629 · Cited by 15
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
